This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sirna Therapeutics, Inc.. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Innovations by Vladislav V Telyatnikov
Introduction
Vladislav V Telyatnikov is an accomplished inventor based in Willow Grove, PA (US). He has made significant contributions to the field of oligonucleotide delivery through his innovative work on cationic lipids. With a total of 2 patents, Telyatnikov's inventions are paving the way for advancements in genetic therapies.
Latest Patents
Telyatnikov's latest patents focus on novel cationic lipids that can be utilized in combination with other lipid components such as cholesterol and PEG-lipids. These innovations aim to form lipid nanoparticles with siRNA, facilitating cellular uptake and endosomal escape. This technology is crucial for effectively knocking down target mRNA both in vitro and in vivo.
Career Highlights
Currently, Telyatnikov is associated with Sirna Therapeutics, Inc., where he continues to develop groundbreaking solutions in the field of biotechnology. His work is instrumental in advancing therapeutic strategies that leverage RNA interference.
Collaborations
Throughout his career, Telyatnikov has collaborated with notable professionals in the industry, including Mark Cameron and Jennifer R Davis. These partnerships have enhanced the scope and impact of his research.
Conclusion
Vladislav V Telyatnikov's contributions to the field of oligonucleotide delivery through his innovative patents are noteworthy. His work at Sirna Therapeutics, Inc. exemplifies the potential of cationic lipids in advancing genetic therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile